English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Saturday, April 20, 2024
Press Releases for Friday, March 23, 2018
Noted Young Filmmakers Share Success Secrets at FILMART
19:00 HKT/SGT
RICS, HKIS enter Mutual Recognition Agreement - Preparing the Profession for Belt and Road and Greater Bay Area initiatives
18:30 HKT/SGT
JCB and Concardis strategic partnership alliance
16:00 HKT/SGT
핀테크 채팅 앱 Consentium, ICO로 미화 천만 달러 기금 마련 및 아시아 출시
15:30 HKT/SGT
AbbVie and Eisai Obtain Additional Approval for New Indication of Fully Human Anti-TNF-alpha Monoclonal
14:41 HKT/SGT
アッヴィとエーザイ、ヒト型抗ヒトTNFαモノクローナル抗体「ヒュミラ(R)」について更なる適応追加として既存治療で効果不十分な膿疱性乾癬に係る承認を取得
14:00 HKT/SGT
エーザイと米メルク、マルチキナーゼ阻害剤「レンビマ」が日本で「切除不能な肝細胞癌」の効能・効果追加の承認を取得
14:00 HKT/SGT
Eisai: Anticancer Agent LENVIMA Approved for Additional Indication of Unresectable Hepatocellular Carcinoma (HCC) in Japan
13:40 HKT/SGT
Hatch is Back! All-New 2019 Toyota Corolla Hatchback Wows at the 2018 New York International Auto Show
13:09 HKT/SGT
マツダ、2019年度の定期採用の計画について
13:00 HKT/SGT
TOYOTA、ニューヨーク国際自動車ショーで新型「カローラハッチバック」を初披露
13:00 HKT/SGT
19 Global Partners Sign for US$850M Project in Lippo Group's MEIKARTA
13:00 HKT/SGT
NEC、AIやRPAを活用した働き方改革を支援するコンサルティングサービス「AI for Work Shift Support 構想・企画サービス」を発売
11:00 HKT/SGT
NEC、KDDIの「auひかり ホーム10ギガ」を支える10G-EPONシステムを提供
11:00 HKT/SGT
日立製作所が5年連続で「なでしこ銘柄」に選定
10:00 HKT/SGT
Etiqa Launches First-ever Free In-flight Insurance for Singapore Travellers
10:00 HKT/SGT
Hitachi Invests in Geodesic Capital Venture Capital Fund, Aiming to Accelerate Open Innovation with Silicon Valley Startups
08:27 HKT/SGT
ACN Search:
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Cookies Policy
|
Privacy Policy
|
Disclaimer
|
Terms of Use
|
RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575